FDA Approves Unknown Drug — GENENTECH INC
GENENTECH INC has received FDA approval for the drug indicated by NDA219285 on February 11, 2025, a decision that is expected to bolster the company's portfolio and impact market dynamics through the anticipated addition of this new therapy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed